
Measles Outbreak Surges Past 300 Cases Across 14 States, CDC Reports Rising Numbers
Measles cases in the U.S. have surged to 301 confirmed cases across 14 states, exceeding the total cases from 2024. The outbreak primarily affects unvaccinated individuals, with Texas reporting the highest number at 259 cases.

father and son using laptop
Key Facts About the Current Outbreak:
- 95% of cases are in unvaccinated people or those with unknown vaccination status
- 229 cases are in people under age 20
- 50 cases required hospitalization
- One confirmed death in Texas (unvaccinated child)
- Cases reported in 14 states including Alaska, California, Florida, and others
Global Impact:
- Europe reported over 127,000 cases in 2024
- Worldwide cases reached 360,000 in 2024
- More than half of European cases required hospitalization
Prevention and Protection:
- MMR vaccine is the only effective prevention method
- Children need two doses: first at 12-15 months, second at 4-6 years
- Vaccinated individuals won't get sick or spread the disease
- High vaccination rates protect vulnerable populations who cannot be vaccinated
Symptoms (appear within 14 days):
- Widespread skin rash
- High fever
- Cough
- Sore throat
Complications (affect 30% of cases):
- Common: ear infections, diarrhea
- Serious: pneumonia, encephalitis
- Can weaken existing immune memory
CDC Recommendations:
- Ensure full vaccination before travel
- Monitor for symptoms for 3 weeks after travel
- Consider measles if temperature exceeds 101°F with rash or cough
- Seek immediate medical attention if symptoms appear
Precautions for Unvaccinated People:
- Avoid mass transportation
- Limit essential travel only
- Take extra care in schools and healthcare facilities
- Stay away from people with respiratory symptoms
- Consider remote work options when possible
The measles virus is highly contagious, spreading through air and direct contact. Vaccination remains the most effective way to prevent its spread and protect vulnerable populations.
Related Articles
Cancer Deaths Drop in U.S., But Women Face Rising Diagnosis Rates
